Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Population-Wide Smallpox Vaccination Urged At Senate Hearing

This article was originally published in The Pink Sheet Daily

Executive Summary

Smallpox vaccination should be reinstated for the entire U.S. population, MIT’s Deutch suggests. Additional research on other biological threats is called for; federal funding is recommended instead of relying on industry initiative, due to lack of market incentives.

You may also be interested in...



Sen. Gregg Eyes Flu Vaccine Manufacturer Liability Protections In Biodefense Bill

The Senate Appropriations/Homeland Security Subcommittee chairman indicates he may consider stronger liability protections for flu vaccine manufacturers in S 3, his biodefense bill.

DynPort’s Immune Globulin Clears FDA For Smallpox Vaccine Complications

Biologic to treat side effects of smallpox vaccination clears FDA based on efficacy data from previously marketed vaccinia immune globulin product. DynPort agrees to conduct a study of the first 100 patients treated as part of accelerated approval post-marketing commitments.

SEC Seeks Vaccine Manufacturer Input On Pediatric Stockpile Accounting

Securities & Exchange Commission regulations on revenue recognition are preventing childhood vaccine manufacturers from selling product to a government stockpile. Rep. Waxman declares support for a special exemption for vaccine makers.

Topics

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel